| Randomized phase III postoperative trial of platinum-based chemotherapy versus capecitabine in patients with residual triple-negative breast cancer following neoadjuvant … IA Mayer, F Zhao, CL Arteaga, WF Symmans, BH Park, BL Burnette, ... Journal of clinical oncology 39 (23), 2539, 2021 | 97 | 2021 |
| Bevacizumab-induced bowel perforation S Sliesoraitis, B Tawfik Journal of Osteopathic Medicine 111 (7), 437-441, 2011 | 75 | 2011 |
| Comorbidity, age, and mortality among adults treated intensively for acute myeloid leukemia (AML) B Tawfik, TS Pardee, S Isom, S Sliesoraitis, A Winter, J Lawrence, ... Journal of geriatric oncology 7 (1), 24-31, 2016 | 72 | 2016 |
| Efficacy of the hypomethylating agents as frontline, salvage, or consolidation therapy in adults with acute myeloid leukemia (AML) B Tawfik, S Sliesoraitis, S Lyerly, HD Klepin, J Lawrence, S Isom, LR Ellis, ... Annals of hematology 93, 47-55, 2014 | 71 | 2014 |
| The neutrophil to albumin ratio as a predictor of pathological complete response in rectal cancer patients following neoadjuvant chemoradiation B Tawfik, AA Mokdad, PM Patel, HC Li, S Huerta Anti-Cancer Drugs 27 (9), 879-883, 2016 | 39 | 2016 |
| House officer–driven reduction in laboratory utilization B Tawfik, JB Collins, NF Fino, DP Miller Jr Southern medical journal 109 (1), 5, 2016 | 12 | 2016 |
| Association between glycemic control, age, and outcomes among intensively treated patients with acute myeloid leukemia P Kuhlman, S Isom, TS Pardee, C Burns, B Tawfik, ZS Lamar, BL Powell, ... Supportive Care in Cancer 27, 2877-2884, 2019 | 11 | 2019 |
| Reducing wait time between admission and chemotherapy initiation A Gupta, J Li, B Tawfik, T Pham, S Pathak, P Singh, E Porsa, N Sadeghi, ... Journal of oncology practice 14 (5), e316-e323, 2018 | 10 | 2018 |
| The RPL/RPS gene signature of melanoma CTCs associates with brain metastasis TY Bowley, IV Lagutina, C Francis, S Sivakumar, RG Selwyn, E Taylor, ... Cancer research communications 2 (11), 1436-1448, 2022 | 9 | 2022 |
| Developing a survivorship care plan (SCP) delivery process for patients and primary care providers serving poor, rural, and minority patients with cancer B Tawfik, SA Jaffe, L Mohler, J Oomen-Hajagos, IS Gil, R Chamberlain, ... Supportive Care in Cancer 29, 5021-5028, 2021 | 9 | 2021 |
| Utility and proposed algorithm of CSF flow cytometry in hematologic malignancies B Tawfik, L Brown, F Fuda, W Chen, S Niu, J Sailors, N Sadeghi Annals of Hematology 97, 1707-1716, 2018 | 9 | 2018 |
| Using big data to gauge effectiveness of breast cancer awareness month D Gathers, VS Pankratz, M Kosich, B Tawfik Preventive medicine 150, 106695, 2021 | 7 | 2021 |
| Patient-reported measures of a breast cancer nurse navigator program in an underserved, rural, and economically disadvantaged patient population MA Williams Number 6/November 2022 49 (6), 532-539, 2022 | 6 | 2022 |
| Pharmacist-driven oral oncolytic medication education and consent H Bowles, B Tawfik, J Abernathy, R Lauer, N Hashemi, Z Dayao JCO Oncology Practice 16 (10), e1209-e1215, 2020 | 5 | 2020 |
| Reaching the “Hard-to-Reach” Sexual and Gender Diverse Communities for Population-Based Research in Cancer Prevention and Control: Methods for Online Survey Data Collection and … KJ Myers, T Jaffe, DA Kanda, VS Pankratz, B Tawfik, E Wu, ME McClain, ... Frontiers in Oncology 12, 841951, 2022 | 4 | 2022 |
| Improving outpatient infusion clinic wait times at a comprehensive cancer center N Hashemi-Sadraei, S Sasankan, N Crozier, B Tawfik, R Kittson, ... JCO Oncology Practice 17 (12), e1935-e1942, 2021 | 4 | 2021 |
| Ischemic stroke in a patient with moderate to severe inherited factor VII deficiency M Reddy, B Tawfik, C Gavva, S Yates, N De Simone, SL Hofmann, ... Transfusion and Apheresis Science 55 (3), 364-367, 2016 | 3 | 2016 |
| Targeting Translation and the Cell Cycle Inversely Affects CTC Metabolism but Not Metastasis TY Bowley, SD Merkley, IV Lagutina, MC Ortiz, M Lee, B Tawfik, ... Cancers 15 (21), 5263, 2023 | 2 | 2023 |
| Re-induction therapy in adult patients with acute myeloid leukemia with≤ 20% blasts: A retrospective cohort study KK Kannan, P Vellanki, S Isom, B Tawfik, A Winter, HD Klepin, LR Ellis, ... Leukemia research 111, 106731, 2021 | 2 | 2021 |
| The novel protease-activated receptor 1 antagonist vorapaxar as a treatment for thrombosis in afibrinogenemia B Tawfik, E Pollard, YM Shen Seminars in Thrombosis and Hemostasis 44 (04), 404-406, 2018 | 2 | 2018 |
Sergio HuertaUniversity of Texas SouthwesternVerified email at va.gov
